Users of NIHRIO information

National Institute for Health Research (NIHR) research programmes

The NIHR Innovation Observatory (NIHRIO) sends information on emerging health technologies that may benefit from additional research to those responsible for research commissioning across NIHR. NIHR programmes of particular relevance are the Health Technology Assessment (HTA), the Efficacy and Mechanism Evaluation (EME) programmes and Invention for Innovation programme. 

National Institute for Health & Care Excellence (NICE)

NIHRIO notifies NICE about emerging drugs and advanced therapy medicinal products and new indications for already licensed products, around 20 months and 15 months before launch into the NHS respectively. NIHRIO aims to provide information on innovative medical devices and diagnostics to NICE medical technologies evaluation and diagnostic assessment programmes up to 24 months prior to commercial availability in the NHS. NIHRIO also provides information to the NICE Interventional Procedures Programme.

NHS England

Emerging drugs and advanced therapy medicinal products identified at the filtration stage for very small patient groups are also sent to NHS England for consideration.

Other users

Other users include policy makers in Scotland, Wales and Northern Ireland; the UK National Screening Committee and programmes;  Public Health England; wider NHS commissioners and providers, health professionals and patients; and the international health technology assessment (HTA) community.